Tailor-made recombinant proteins in mammals

A new way to direct chemical modifications to specific sites on recombinant proteins - including the monoclonal antibodies so important in the pharmaceutical industry - has been developed by Carolyn Bertozzi and her colleagues at the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California at Berkeley.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news153404398.html">Tailor-made recombinant proteins in mammals</a></p> <p>A new way to direct chemical modifications to specific sites on recombinant proteins - including the monoclonal antibodies so important in the pharmaceutical industry - has been developed by Carolyn Bertozzi and her colleagues at the U.S. Department of Energy's Lawrence Berkeley National Laboratory and the University of California at Berkeley.</p>